Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 7,497 | 4,850 | 5,170 | 6,915 | 3,555 |
| Operating Income | -7,497 | -4,850 | -5,170 | -6,915 | -3,555 |
| Interest Expense | 121 | 121 | 117 | 116 | 59 |
| Other Income | 11 | 8 | 14 | 24 | 6 |
| Pre-tax Income | -7,607 | -4,963 | -5,273 | -7,007 | -3,608 |
| Net Income Continuous | -7,607 | -4,963 | -5,273 | -7,007 | -3,608 |
| Net Income | $-7,607 | $-4,963 | $-5,273 | $-7,007 | $-3,608 |
| EPS Basic Total Ops | -1.80 | -1.40 | -1.48 | -2.00 | 52.48 |
| EPS Basic Continuous Ops | -1.57 | -1.62 | -1.48 | -1.99 | 36.83 |
| EPS Diluted Total Ops | -1.80 | -1.40 | -1.48 | -2.00 | 52.48 |
| EPS Diluted Continuous Ops | -1.57 | -1.62 | -1.48 | -1.99 | 36.83 |
| EBITDA(a) | $-7,490 | $-4,847 | $-5,164 | $-6,911 | $-3,556 |